Swiss drugmaker Novartis has launched legal action against the US Government, after authorities revealed the first drugs to be subject to pricing regulations ma 7 September 2023
The National Institute for Health and Care Excellence (NICE) has published Final Guidance on a new medicine for the treatment of the most common inherited heart 6 September 2023
Idorsia is to pay up to $345 million to reacquire rights to aprocitentan, a novel endothelin receptor blocker under development for hypertension. 6 September 2023
Since first demonstrating clinical success in the treatment of obesity, Wegovy (semaglutide) has garnered ever increasing amounts of interest from patients, pro 4 September 2023
US biotech Cytokinetics is seeking to develop medicines that treat cardiovascular and neuromuscular diseases of impaired muscle function. 15 August 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.